Matthew Tarler

Director, Quality & Regulatory, R & D at CleveMed (Cleveland Medical Devices Inc.)

Dr. Tarler holds a Ph.D. degree in Biomedical Engineering from Case Western Reserve University, is a principal investigator on a number of National Institutes of Health (NIH) grants, and has numerous awards, over 30 publications, and 8 issued patents to his name. With over a dozen years of experience at CleveMed, Dr. Tarler has been instrumental in the development of a wide array of technologies that have resulted in patents and commercial products alike. Some of Dr. Tarler’s recent work include co-inventing a new self-abrading and rapidly applied EEG electrode, designing and developing a device for delivering a controlled level of CO2 to treat patients with a chemoreflex-modulated sleep disorder, design, and development of a new echolocation device to determine the actual location of apnea obstructions, investigating a new and novel use of electrical stimulation to treat chemoreflex-modulated sleep disorder patients, and developing new and novel sleep monitors with minimal sensors.